NEXGEL (NXGLW) Competitors $0.34 0.00 (0.00%) As of 10/9/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NXGLW vs. DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, LUCYW, IINNW, NVACW, and NTRBWShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), NorthView Acquisition (NVACW), and Nutriband (NTRBW). These companies are all part of the "medical equipment" industry. NEXGEL vs. Its Competitors Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NorthView Acquisition Nutriband NEXGEL (NASDAQ:NXGLW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends. Does the media refer more to NXGLW or DRTSW? In the previous week, NEXGEL and NEXGEL both had 1 articles in the media. Alpha Tau Medical's average media sentiment score of 1.91 beat NEXGEL's score of 1.89 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment NEXGEL Very Positive Alpha Tau Medical Very Positive Is NXGLW or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets NEXGELN/A N/A N/A Alpha Tau Medical N/A N/A N/A Which has higher valuation and earnings, NXGLW or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNEXGEL$11.67MN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A SummaryNEXGEL and Alpha Tau Medical tied by winning 1 of the 2 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGLW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGLW vs. The Competition Export to ExcelMetricNEXGELMedical Instruments & Supplies IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.82B$6.07B$10.42BDividend YieldN/A2.04%5.66%4.69%P/E RatioN/A255.7885.5326.92Price / SalesN/A93.83588.18180.92Price / CashN/A146.5438.3262.20Price / BookN/A2.3812.776.64Net IncomeN/A$99.80M$3.30B$275.87M7 Day Performance11.84%-1.05%1.85%0.07%1 Month Performance16.90%1.35%8.45%6.93%1 Year Performance-28.56%116.26%80.37%34.31% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLWNEXGELN/A$0.34flatN/AN/A$0.00$11.67M0.0010Positive NewsGap DownDRTSWAlpha Tau MedicalN/A$0.37+7.8%N/A+76.2%$0.00N/A0.0080Positive NewsGap DownANZUWAnzu Special Acquisition Corp IN/A$0.04-6.6%N/AN/A$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.01+44.0%N/A-66.0%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.39-3.7%N/AN/A$0.00N/A0.002HSCSWHeart Test LaboratoriesN/A$0.09-32.7%N/A+81.0%$0.00$6.25K0.0010Gap DownBEATWHeartBeamN/A$0.29-0.3%N/A-46.9%$0.00N/A0.005Positive NewsGap DownLUCYWInnovative EyewearN/A$0.08+10.4%N/A+202.7%$0.00$1.98M0.009Positive NewsGap DownIINNWInspira Technologies Oxy B.H.N.N/A$0.41+13.0%N/A+66.8%$0.00N/A0.0020Gap UpNVACWNorthView AcquisitionN/A$0.18flatN/AN/A$0.00N/A0.002NTRBWNutribandN/A$1.90+45.0%N/A+60.2%$0.00$2.58M0.0010News CoverageGap Up Related Companies and Tools Related Companies Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Heart Test Laboratories Alternatives HeartBeam Alternatives Innovative Eyewear Alternatives Inspira Technologies Oxy B.H.N. Alternatives NorthView Acquisition Alternatives Nutriband Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGLW) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsoleteWhen a new chip can run at the speed of light, the game changes. This is the reality of “TF3” — a man-made...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
